JR Pharma Engineering ApS Financials, key figures and credit report
Net sales 2 000.2 kDKK FY 2025 +3.9% vs 2024
EBIT margin 27.7 % FY 2025 -11.7 pp vs 2024
Net debt - 506.0 kDKK FY 2025 +10.6% vs 2024
Quick ratio 2.0 FY 2025 -0.7 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 1 481.60 | 1 865.52 | 1 959.82 | 1 925.86 | 2 000.22 |
| External services | -20.73 | -40.02 | -13.48 | ||
| Gross profit | 1 460.87 | 1 806.00 | 1 947.12 | 1 908.04 | 1 959.07 |
| Costs of management | -19.50 | -12.70 | -17.82 | -27.67 | |
| Employee benefit expenses | - 717.18 | ||||
| Total depreciation | -5.60 | -25.06 | -1.56 | -11.54 | |
| EBIT | 738.09 | 828.35 | 842.69 | 758.50 | 554.74 |
| Other financial expenses | -2.94 | -1.06 | -0.13 | -0.61 | |
| Pre-tax profit | 735.16 | 827.29 | 842.56 | 758.50 | 554.13 |
| Income taxes | - 161.84 | - 182.00 | - 191.84 | - 166.87 | - 122.04 |
| Net earnings | 573.31 | 645.28 | 650.72 | 591.63 | 432.09 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 330.50 | 468.15 | 421.31 | 432.69 | 444.69 |
| Current deferred tax assets | 200.00 | ||||
| Short term receivables total | 530.50 | 468.15 | 421.31 | 432.69 | 444.69 |
| Cash and bank deposits | 388.35 | 765.34 | 668.10 | 565.92 | 505.98 |
| Cash and cash equivalents | 388.35 | 765.34 | 668.10 | 565.92 | 505.98 |
| Balance sheet total (assets) | 918.85 | 1 233.49 | 1 089.41 | 998.61 | 950.68 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 41.78 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -0.00 | 1.94 | 1.94 | 1.94 | 1.94 |
| Profit of the financial year | 573.31 | 645.28 | 650.72 | 591.63 | 432.09 |
| Shareholders equity total | 615.09 | 687.23 | 692.66 | 633.57 | 474.03 |
| Non-current liabilities total | |||||
| Current trade creditors | 31.68 | 0.78 | 0.31 | 17.16 | |
| Short-term deferred tax liabilities | 161.84 | 343.85 | 111.05 | 90.83 | 44.61 |
| Other non-interest bearing current liabilities | 141.92 | 170.73 | 284.92 | 273.90 | 414.88 |
| Current liabilities total | 303.76 | 546.26 | 396.75 | 365.04 | 476.64 |
| Balance sheet total (liabilities) | 918.85 | 1 233.49 | 1 089.41 | 998.61 | 950.68 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated